Proteonomix, Inc.
PROT · OTC
12/31/2011 | 12/31/2010 | 12/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -109.57% | -330.58% | -62.52% | -7.47% |
| EV / EBITDA | -4.05 | -1.37 | -0.73 | -1.62 |
| Quality | ||||
| ROIC | 604.72% | -493.29% | 196.04% | 401.58% |
| Gross Margin | 101.97% | 80.98% | 83.63% | 86.74% |
| Cash Conversion Ratio | – | 0.16 | 0.05 | 0.02 |
| Growth | ||||
| Revenue 3-Year CAGR | -43.17% | -14.23% | -11.84% | -34.19% |
| Free Cash Flow Growth | 59.58% | -279.31% | -84.71% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -3.74 | -1.29 | -0.64 | -1.31 |
| Interest Coverage | -17.05 | -181.33 | -97.25 | -23.16 |
| Efficiency | ||||
| Inventory Turnover | -0.00 | 0.08 | 0.12 | 0.09 |
| Cash Conversion Cycle | -135,953.89 | 4,380.56 | 3,136.79 | 4,377.29 |